Pfizer, BioNTech start trial on one vaccine to prevent both Covid-19, influenza
HQ Team November 4, 2022: The US-based drugmaker Pfizer Inc and Germany’s BioNTech have started clinical trials for a vaccine to prevent both.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team November 4, 2022: The US-based drugmaker Pfizer Inc and Germany’s BioNTech have started clinical trials for a vaccine to prevent both.
The FDA has told healthcare providers to consider different MRI-guided breast biopsy procedure options due to a shortage of grid plates and coil.
Alembic Pharmaceuticals, an Indian maker of generic drugs, announced it had received USFDA's final approval for Paclitaxel injection multi-dose vials for use in.
USFDA approves Zydus Lifesciences anti-fungal injection HQ Team October 26, 2022: Zydus Lifesciences announced that it had received final approval from the USFDA.
HQ Team October 26, 2022: Aurobindo Pharma US has initiated a voluntary recall of two lots of tablets in the American market due to the.
HQ team Koninklijke Philips N.V., an Amsterdam-based healthcare technology company, plans to slash 4,000 jobs after sales fell following a vast recall of.
HT Team October 18, 2022: The USFDA has inspected India’s Alembic Pharmaceuticals’ Oncology Injectable Formulation Facility at Panelav, Gujarat, according to a BSE.
September 22, 2022: Lupin Ltd., one of the top Indian pharmaceutical majors, has received approval from the US drug regulator United States Food.
Zydus Lifesciences gets initial USFDA approval for Sugammadex